Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

PHASE3CompletedINTERVENTIONAL
Enrollment

575

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

March 31, 2002

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

temozolomide

RADIATION

radiation therapy

Trial Locations (16)

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V3V 1Z2

British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey

V5Z 4E6

British Columbia Cancer Agency, Vancouver

V8R 6V5

British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 8X3

Doctor Leon Richard Oncology Centre, Moncton

E2L 4L2

Saint John Regional Hospital, Saint John

A1B 3V6

Newfoundland Cancer Treatment and Research Foundation, St. John's

B3H 1V7

Nova Scotia Cancer Centre, Halifax

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

K1H 1C4

Ottawa Regional Cancer Centre - General Campus, Ottawa

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

N8W 2X3

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor

H2L-4M1

Centre Hospitalier de l'Universite de Montreal, Montreal

Sponsors
All Listed Sponsors
collaborator

NCIC Clinical Trials Group

NETWORK

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK